搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
14 小时
Pfizer gets a leg up in RSV as FDA clears jab for all adults
A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival ...
pharmaphorum
16 小时
UK 'should abolish clock changes on health grounds'
Many will celebrate having an extra hour in bed – perhaps forgetting how they lost an hour at the end of March when the ...
pharmaphorum
11 小时
Unlocking impact and growth at times of demerger
In conclusion, a demerger, like any major pivot, is a high-stakes, high-value moment where everything matters. Reconnect to ...
pharmaphorum
11 小时
The power of patient insights in shaping successful drug development
The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development like ...
pharmaphorum
13 小时
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to ...
pharmaphorum
17 小时
Starboard spells out its concerns with Pfizer's direction
Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...
pharmaphorum
15 小时
Creating True Value with GenAI
Pharma companies are moving their Generative AI (GenAI) investments from pilot to production through exploration, ...
pharmaphorum
15 小时
Lawmakers seek answers on Pfizer, Lilly telehealth moves
Discussing Pfizer's platform, the lawmakers write that it "creates the impression that any patient interested in a particular ...
pharmaphorum
2 天
FDA clears Astellas' Vyloy as first claudin 18.2 cancer drug
Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU ...
pharmaphorum
2 天
The role of quality assurance in accelerating drug development for emerging therapies
The increasing complexity of emerging therapies and the need for faster development have led to the adoption of advanced ...
pharmaphorum
1 天
Seven pillars of GenAI for enterprise-level value generation
To learn more about the true value of AI and GenAI in pharma, pharmaphorum spoke with Sudip Chakraborty, Principal and Head ...
pharmaphorum
1 天
Otsuka eyes early filing of IgAN drug after phase 3 readout
The Japanese drugmaker said that interim results from the 530-patient VISIONARY study showed that sibeprenlimab achieved a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈